<SEC-DOCUMENT>0001193125-19-000206.txt : 20190102
<SEC-HEADER>0001193125-19-000206.hdr.sgml : 20190102
<ACCEPTANCE-DATETIME>20190102095405
ACCESSION NUMBER:		0001193125-19-000206
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20190102
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190102
DATE AS OF CHANGE:		20190102

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WESTLAKE CHEMICAL CORP
		CENTRAL INDEX KEY:			0001262823
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL ORGANIC CHEMICALS [2860]
		IRS NUMBER:				760346924
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32260
		FILM NUMBER:		19500321

	BUSINESS ADDRESS:	
		STREET 1:		2801 POST OAK BLVD
		STREET 2:		SUITE 600
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77056
		BUSINESS PHONE:		713-960-9111

	MAIL ADDRESS:	
		STREET 1:		2801 POST OAK BLVD
		STREET 2:		SUITE 600
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77056
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d684908d8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML><HEAD>
<TITLE>8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">8-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT
REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant to Section&nbsp;13 or 15(d) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (date of earliest event reported): January&nbsp;2, 2019 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Westlake Chemical Corporation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">001-32260</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">76-0346924</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2801 Post Oak Boulevard, Suite 600</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Houston, Texas</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>77056</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code:
<FONT STYLE="white-space:nowrap">(713)&nbsp;960-9111</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below
if the Form <FONT STYLE="white-space:nowrap">8-K</FONT> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting material pursuant to Rule <FONT STYLE="white-space:nowrap">14a-12</FONT> under the Exchange Act (17
CFR <FONT STYLE="white-space:nowrap">240.14a-12)</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT
STYLE="white-space:nowrap">14d-2(b)</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.14d-2(b))</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT
STYLE="white-space:nowrap">13e-4(c)</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.13e-4(c))</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Securities Exchange Act of 1934 <FONT STYLE="white-space:nowrap">(&#167;240.12b-2</FONT> of this chapter). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange
Act.&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;7.01.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Regulation FD Disclosure. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;2, 2019, Westlake Chemical Corporation issued a press release announcing that it completed its previously announced acquisition
of NAKAN&#153;, a global compounding solutions business. A copy of the press release is furnished with this Current Report as Exhibit 99.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information furnished pursuant to this Current Report, including Exhibit 99.1, shall not be deemed to be &#147;filed&#148; for the
purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), or otherwise subject to the liability of such section, nor shall such information be deemed incorporated by reference into any filing by
Westlake Chemical Corporation under the Securities Act of 1933, as amended, or the Exchange Act, unless specifically identified as being incorporated therein. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Financial Statements and Exhibits. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Exhibits </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following
exhibit is furnished herewith: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d684908dex991.htm">Press release issued on January&nbsp;2, 2019. </A></TD></TR>
</TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WESTLAKE CHEMICAL</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CORPORATION</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:&nbsp;January 2, 2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ L. BENJAMIN EDERINGTON</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>L. Benjamin Ederington</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Senior Vice President, General Counsel,</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Chief Administrative Officer and</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Corporate Secretary</B></P></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d684908dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g684908g0102185843358.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WESTLAKE CHEMICAL CLOSES PURCHASE OF NAKAN PVC COMPOUNDING SOLUTIONS BUSINESS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>HOUSTON</B><B>, January 02, 2019</B> &#150; Westlake Chemical Corporation (NYSE: WLK) today completed the previously announced acquisition of NAKAN&#153;,
a global compounding solutions business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NAKAN&#146;s products are used in a wide-variety of applications, including in the automotive, building and
construction, and medical industries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The combination of NAKAN with Westlake&#146;s existing compounding business represents an excellent strategic
fit. It will allow us to expand our compounding business globally and add important specialty products and technology to our existing portfolio,&#148; said Albert Chao, president and chief executive officer of Westlake Chemical Corporation.
&#147;NAKAN brings an impressive business with an outstanding reputation for meeting customer needs with superior technology, product quality, and operating excellence. We are pleased to welcome their talented team into the Westlake family of
companies.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With this combination, Westlake&#146;s compounding business now has facilities worldwide in China, France, Germany, Italy, Japan,
Mexico, Spain, the United States and Vietnam, as well as a world-class research facility in France and several application laboratories. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About
Westlake Chemical Corporation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Westlake Chemical Corporation is an international manufacturer and supplier of petrochemicals, polymers and building
products with headquarters in Houston. The company&#146;s range of products includes: ethylene, polyethylene, styrene, propylene, chlor-alkali and derivative products, PVC suspension and specialty resins, PVC compounds, and PVC building products
including siding, pipe, fittings and specialty components, windows, fence, deck and film. For more information, visit the company&#146;s website at <U>www.westlake.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About NAKAN </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NAKAN is a global leader in PVC, TPE and TPO
compounds for selected markets: Automotive Industry, Healthcare, Packaging, Consumer Goods, Building and Construction. The wide range of Nakan products includes rigid and flexible grades for extrusion, injection, pressing and roto-molding: a full
set of possibilities for manufacturers and <FONT STYLE="white-space:nowrap">end-users</FONT> to answer any specific application. For more information, visit the company&#146;s website at <U>www.nakan.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cautionary Statement Regarding Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve certain
risks and uncertainties. These risks and uncertainties relate to, among other things, the risks and uncertainties inherent in the petrochemicals, polymers and building products industries discussed in our filings with the Securities and Exchange
Commission, as well as the risks and uncertainties inherent in the transaction involving NAKAN. Forward-looking statements, like all statements in this press release, speak only as of the date of this press release (unless another date is
indicated). We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of new information, future events, or otherwise. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Contacts: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Media Inquiries: Benjamin Ederington, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-713-960-9111;</FONT></FONT></FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investor Inquiries:
Steve Bender, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-713-960-9111</FONT></FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g684908g0102185843358.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g684908g0102185843358.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  \ +D# 2(  A$! Q$!_\0
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MV_\ 9EC_ ,^EO_WZ%']F6/\ SYV__?H5G>&O$UCXITV2^T]91%'*8SYHP2P
M/J?45H65^EU)<1HKJT#[&W 8S[8J6IIM/H4N1VMU%_LRQ_Y](/\ OT*/[-L?
M^?*#_OTM4];UB/0K%KVXMKB6"-<N\"@[!W.,@X^E+H&OVWB/25U*QCE6!V94
M\U=I.#C/4\4>]:_0+0O:VI9TZ-(DN$C5519VPJC '2K]4['K<_\ 7PW]*X;X
MQ6=T/!%UJVG7EU;7EB%8-!.R90L P(! /!SSZ4GN5'8]%HKROP=XB72O@L/$
M9EGNKUHFW":5I&DN-YC0#)/4[>!57X->(I?$/A75=#U6YF-W9RN)6=R',4F>
M^<@AMW0\9%(H]>HKSGX:)';>'+KQ%?:A<F"\GF:!KNZ9EAM@Y"#YC@<#.>IS
M75:3XMT'6[AK33-5M[F=%R45L-CU P,CZ4 ;E%8&J>,O#VBW36VH:K!!<(N6
MCP6*#U. <#ZXKG_B3XVF\.>!8=;T26WFDN942&1CN!5@3N [G@4 =_2*RNNY
M6#*>A!R*\N\>W,.L?!ZXU&/41+>6EK%(TMM/C$AV;LA3CG)X/K6[\,9$M_A;
MH4LSA46U+N[MP!N)))/2@#M::SJHRS!03CDXYK T[QGX=UB_-EI^LVL]SR/+
M1^3CKC(P?PKS/XDVGV;XK^"GBDG OKQ&F0S,4)61 "%)P.#V H ]MHK,O]>T
MK2KF"WOK^&WFG_U4<C?,_..!UHU36M,T. 2ZG?16L;?*ID;!8^@'4_@* -.B
ML[2=9T_6K476F7T-W#G!:)LX/H>X/UK1H IZ;_R"[3_KBG\A7)^+K3RKZ*Y4
M<3+AOJ/_ *W\JZS3?^07:?\ 7%/Y"J'B>T^TZ+*P&7A/F+^'7],UO0J<E5,Y
M:]/GHV\CF?#-U]FUA$)PDPV'Z]OUKRKXE:2-(\<WRHNV&ZQ<Q\<?-][_ ,>!
M_.N_CD:.1)$.&0A@?<55^,.GK?:#I.OPKDQGRI"/[KC(_(C'XUZ<OW>(C+^;
M0\ZB^>C*';4ROA!X@&G2ZKI\K?*\7VF)?5UX('U!'Y5[+I%LUK8KYO,TF9)3
MZL>37S!X;U%-)\2Z=>R?ZJ*X7S?=<\_IFOJQ2&16!!&,Y'<5QXZ'+.ZZG9A'
MS+7H<OX]OGA\-R6-L-U[J3BQMU]WX)^@&36WHVF0Z1I-IIUN,16T2Q+^ Y/X
MUSD&=>^(4UQC=9Z'&88O1KEQEC_P%>/QKLZXY:)1^9UQU;D5;'K<_P#7PW]*
MJ^(].&L>&M3TT@$W5I)$/JRD#]:M6/6Y_P"OAOZ5;I,J.Q\X?!E[OQ";'P[-
M$W]GZ/?OJ<Y/0MM B3_OO<WX5#XS-[\/OBMJTFFQMY6O6<@B5>!OE!'YB3!_
M&O;_  KX.T_PDVHMI^XG4+EKB0MV]%'L.<?6D\1^#-,\3ZKH^H7VX3:7/YT6
MW^/D':WME12*/,?BS&_AWP]X(T"(*;&.58YT=L)(8P@PV.QRQ/XUO3^"O$6J
M_$'0_$SPZ=IJ6!595M9"?-CR3CIZ$BNV\6>$M.\8:/\ 8-15B%</'(GWD;U'
MZUC>'O EUH=Q:M<^)]2O[:T/[BVD8!!Q@9QUQGB@#SZX_P"$N\%Z_P")-8M=
M)M=<T:^N9)I93\Y10S J>XQR"/:JWCRZTG6?@/HFJ6-D;=(9TMH4<[FB"EU9
M0WI\O\J](D\!7>-2M;7Q+>V^FZA+++-;!%.WS"2X5CR <FK6J?#[1]2\#1>$
MPCP64.TQ%/O*P.=WOG)S]: ,+Q?I>GZ5\$-56QM(;=9K**201)@.QV<GWJII
MNK:/H_P"TF?7(VELWMDC,*'F4EB0O_CN3]*WF^',,O@[_A')-9U![8_Z]RP+
M2 8POL!@=*;-\,-/NO!/_"*W.H7<MFDBO;,V-T!&< >HY/7UH \W\11S#XD>
M ]2_LBWTDWEQ'L2%\LR;T(WXXSAL?G6Y\7I)X_B-X%>TB26Y6=FAC=L*[>8F
MT$]AG&:Z!OA'I\ATF9M6U%KS3,&*X,F6R""/H!@8%:'B#X<0>(]=L]8N]7O5
MN+)E:UV8 C(P<C\0#0!RWPOURSUOQ)JW_"06^WQ<LK!UG'W8AT2,'ICOCKUJ
MA>ZCJ5Q^T)>VR6UM=2VUH([.&[?:BC8C$K_M'+?K7;ZS\,].UC7+36OMMU::
MK;1JINK<A6D(Z,WO_C3/%7PTL?$FJ6NII?7-CJ]L@5;R X9L="??WH J^ ?!
MFL^&_$^OZM>_98;74V\Q;2W8E8WW%OZG\Z](KG?#OAV?0UFDO-8O=4N9@H:2
MY;A0,X '0=:Z*@"IIO\ R"[3_KBG\A4\J+)&R.,JPP1[5!IO_(+M/^N*?R%6
MZ?4F/PH\LNK<VMW-;MUC<J/IV_2M-[5=?\ :KI#D>8D;&//8CYU/YBIO%MGY
M6IK<*ORS)SQW'_UJS]*,GVM;8,56X(B<_P"SG/\ 2O7DU4HJ5]=_N/'BG3K.
M-M-OO/! "PY&.Q%?0OAKQ=&/A;'J\QWS6<!@=0>7E7"J/J?E_.O'O&^C'0_&
M.I6B1E86D\V$#IM?D#\.16U\,C-J.MP:),^+!9_[0>-O^6CQC"K^>#_P&EB5
M&K24NVIK0<J=1Q[Z'L_A+2)-&\/017+;KR4FXNG_ +TKG<WY9Q704F!Z4M>2
MVV[L]1*RLBI8];G_ *^&_I7*?$?QU'X(T!;E8_.O[E_+M82>"P_B/L/\*ZNQ
MZW/_ %\-_2O$_P!H:&:&]\,ZH49[6"217'8-E&'YX_2ABCL=II/A?Q/JMC%>
MZ]XHOK:\E4.;>T 1(<\@>Y%-M[#Q);0>)=.OM:NI8+:VCEL+X*$DSM<D$]#@
MJ!^-=W9W4.H6D5Y;2+)!,@='4\$'H:9K/_(#U#_KVD_]!-(H\W^#'B!Y_ <]
M_KFI[I9-0D42W,GHB< FO4$=)8Q(C*Z.,A@<@^^:^=_ ?@[2O$/P<U>^U!99
M)K8W#6Q\PA82L8;('KGKGM6GX<\0ZEI/[-EYJ,,[_:897@@<G)C5I%7CZ;C^
ME 'MG]J:?]J^R?;+?[1G_5>8-V?I3Y[VUMR!/<1Q,Q"@.X!)/  ^M>!'PWJ/
MB3X?Z$VA>&YXM779<_VL9T#2G!W$MG/)['IBM#XO:41J?@F:YW1W]W.L5Y)$
MYR6'E#CL,9;!]Z /:H]4L)KJ2TBNH7N$^_&K@L/PHM-3L;R9XK6[AFD0D.J2
M D$<=*\/\8^%-.T/XN^%8-+:>T34FV7)BF;<_P ^&^8G/S X-6?[%M?"G[1.
MBV>BH;:UN[0O+$&)#?+(#G/7[H- '<ZOIVLR_$K2=1@UZ*#2XTV2V)<9D;#9
M '?.1^5=M//#;0M+-*D<:=6<@ ?B:\9\26-M:?M%>%O)C*BXB,\HW'!D_>\\
M].@JYJ]T/%7QR'A75&9]'L;3SEM-Q"S2%0WS8ZC#=/\ 9H ]5M+ZSOD,EK<Q
M3HIP6C<, >M10:MIUU<-!!?6\LR9W(D@)'KQ7&7GASP[X'\.>))I+I]/TK49
M$8B D-$-H4JAZY)R?QKS'6H;*Q\?>"=6T#1;G1HKV[15:0X^T)OCYVY)P0W?
MJ"* .L^)]WJFF?$'PE#:ZM=I;:E>();</A,+)&,#O_$:]GKQ?XP_\E&^'G_7
M[_[5BKVB@"CIO_(+M/\ KBG\A5RN)L?$EXEK$@C@VI&N/E/I]:F_X2>^_P">
M<'_?)_QJW'5F$:JY5H=:\4<F-Z*V.FX9Q31;P*P811@@Y!"CBN3_ .$HOO\
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>+%OFY&5[?2NB^Q>+O^@WIG_@"W_Q==%@>@HH __9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
